You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 2, February 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Ophthalmology, Other
 •Articles for Residents
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Gyrate Atrophy of the Choroid and Retina

Further Experience With Long-term Reduction of Ornithine Levels in Children

Muriel I. Kaiser-Kupfer, MD; Rafael C. Caruso, MD; David Valle, MD

Arch Ophthalmol. 2002;120:146-153.

Objective  To determine whether the long-term reduction of plasma ornithine levels by way of an arginine-restricted diet in patients with gyrate atrophy will slow the progression of this chorioretinal degeneration.

Design  Natural history study of 2 pairs of siblings with gyrate atrophy treated with an arginine-restricted diet.

Main Outcome Measures  Fundus photography and electrophysical and psychophysical retinal function tests.

Results  After 16 to 17 years of receiving an arginine-restricted diet, the younger sibling in each pair, who was prescribed the diet at an earlier age than the older sibling, demonstrated a slower progression of lesions compared with the older sibling.

Conclusions  If started at an early age, long-term substantial reduction of plasma ornithine levels may appreciably slow the progression of the chorioretinal lesions and, to a lesser extent, the progressive loss of retinal function in patients with gyrate atrophy.


From the National Eye Institute, National Institutes of Health, Bethesda, Md (Drs Kaiser-Kupfer and Caruso); and the McKusick-Nathans Institute of Genetic Medicine and Howard Hughes Medical Institutes, Johns Hopkins University School of Medicine, Baltimore, Md (Dr Valle).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Ophthalmology Reader's Choice: Continuing Medical Education
Arch Ophthalmol. 2002;120(2):243.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Myopathy with tubular aggregates and gyrate atrophy of the choroid and retina due to hyperornithinaemia
Fleury et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:656-657.
FULL TEXT  

Cytotoxic Effect of Spermine on Retinal Pigment Epithelial Cells
Kaneko et al.
IOVS 2007;48:455-463.
ABSTRACT | FULL TEXT  

Use of an Arginine-Restricted Diet to Slow Progression of Visual Loss in Patients With Gyrate Atrophy
Kaiser-Kupfer et al.
Arch Ophthalmol 2004;122:982-984.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.